Document is current
Any future updates will be listed below
-
Authors
Blaskovich, Mark A. T. http://orcid.org/0000-0001-9447-2292
Kavanagh, Angela M.
Elliott, Alysha G. http://orcid.org/0000-0002-2983-0484
Zhang, Bing http://orcid.org/0000-0001-8405-9242
Ramu, Soumya
Amado, Maite
Lowe, Gabrielle J.
Hinton, Alexandra O.
Pham, Do Minh Thu
Zuegg, Johannes
Beare, Neil
Quach, Diana
Sharp, Marc D.
Pogliano, Joe
Rogers, Ashleigh P.
Lyras, Dena http://orcid.org/0000-0003-2345-9271
Tan, Lendl http://orcid.org/0000-0002-9955-2440
West, Nicholas P. http://orcid.org/0000-0003-0955-9890
Crawford, David W.
Peterson, Marnie L.
Callahan, Matthew
Thurn, Michael
- License Information
-
More Information
Article History
Received: 8 July 2020
Accepted: 20 November 2020
First Online: 19 January 2021
Competing interests
: The authors declare the following competing interests: M.C. and M.T. are employees of Botanix Inc, who co-funded most of this research. M.A.T.B. consults for Botanix Inc., and is an inventor on several antibiotic patents (unrelated to this work) which are undergoing commercialization. D.Q. and M.D.S. are employees and J.P. founded Linneas (conducted the bacterial cytological profiling). J.P. has an equity interest in Linnaeus Bioscience Incorporated and receives consulting income from the company. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. N.B. is founder of BDG Synthesis (conducted the analog synthesis), and D.W.C. is an employee and M.L.P. founded Extherid Biosciences (conducted the ex-vivo pig skin studies), which is now part of Perfectus Biomed Group. The remaining authors declare no competing interests.
